Evaxion Biotech A/S (EVAX) Institutional Ownership $1.76 +0.04 (+2.02%) As of 01:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Evaxion Biotech A/S (NASDAQ:EVAX)CurrentInstitutional OwnershipPercentage11.04%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$2.60MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$167.94K Get EVAX Insider Trade Alerts Want to know when executives and insiders are buying or selling Evaxion Biotech A/S stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EVAX Institutional Buying and Selling by Quarter Evaxion Biotech A/S Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2025 Merck & Co. Inc.1,214,126$2.25M1.4%+123.9%86.538% 5/8/2025 XTX Topco Ltd16,281$30K0.0%N/A1.160% 2/19/2025Invst LLC50,400$43K0.0%+16.7%4.308% 1/24/2025 Catalina Capital Group LLC34,864$29K0.0%N/A2.980% 11/19/2024Invst LLC43,200$134K0.0%-20.0%0.736% 8/16/2024Invst LLC54,000$156K0.0%N/A0.998% 8/15/2024 Armistice Capital LLC392,000$1.14M0.0%+6.8%7.245% 2/14/2024 LM Advisors LLC337,336$231K0.0%N/A8.898% 1/9/2024 Beacon Capital Management LLC48,633$33K0.0%+606.8%0.173% 10/11/2023 AE Wealth Management LLC48,633$41K0.0%N/A0.176% 5/12/2023 Moloney Securities Asset Management LLC36,000$41K0.0%N/A0.142% 2/14/2023 Pura Vida Investments LLC16,842$30K0.0%N/A0.071% 11/17/2022Telemetry Investments L.L.C.29,000$76K0.1%-76.2%0.122% 11/16/2021Telemetry Investments L.L.C.30,743$296K0.4%-26.3%0.160% 11/12/2021Credit Suisse AG40,315$389K0.0%N/A0.210% 8/16/2021 Maven Securities LTD235,606$1.76M0.1%+2.2%1.227% 8/16/2021Telemetry Investments L.L.C.41,729$315K0.4%-43.5%0.217% 5/18/2021 Luminus Management LLC194,929$1.15M0.2%N/A1.015% 5/18/2021 Alyeska Investment Group L.P.86,726$512K0.0%N/A0.452% 5/13/2021 Kepos Capital LP37,098$219K0.0%N/A0.193% 5/12/2021Granite Point Capital Management L.P.224,601$1.33M0.0%N/A1.170% (Data available from 1/1/2016 forward) EVAX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EVAX shares? During the previous two years, the following institutional investors and hedge funds held shares of Evaxion Biotech A/S shares: Merck & Co. Inc. ($2.25M), Armistice Capital LLC ($1.14M), LM Advisors LLC ($231K), Invst LLC ($43K), AE Wealth Management LLC ($41K), Beacon Capital Management LLC ($33K), and XTX Topco Ltd ($30K).Learn more on EVAX's institutional investors. What percentage of Evaxion Biotech A/S stock is owned by institutional investors? 11.04% of Evaxion Biotech A/S stock is owned by institutional investors. Learn more on EVAX's institutional investor holdings. Which institutional investors have been buying Evaxion Biotech A/S stock? The following institutional investors have purchased Evaxion Biotech A/S stock in the last 24 months: Merck & Co. Inc. ($671.85K), LM Advisors LLC ($337.34K), Invst LLC ($61.20K), AE Wealth Management LLC ($48.63K), Beacon Capital Management LLC ($41.75K), Catalina Capital Group LLC ($34.86K), and Armistice Capital LLC ($25K). How much institutional buying is happening at Evaxion Biotech A/S? Institutional investors have bought a total of 1,236,913 shares in the last 24 months. This purchase volume represents approximately $17.62M in transactions. Which Evaxion Biotech A/S major shareholders have been selling company stock? The following institutional investors have sold Evaxion Biotech A/S stock in the last 24 months: Invst LLC ($10.80K). How much institutional selling is happening at Evaxion Biotech A/S? Institutional investors have sold a total of 10,800 shares in the last 24 months. This volume of shares sold represents approximately $167.94K in transactions. Related Companies TransCode Therapeutics Institutional Ownership Addex Therapeutics Institutional Ownership Cardio Diagnostics Institutional Ownership BioXcel Therapeutics Institutional Ownership Carisma Therapeutics Institutional Ownership Portage Biotech Institutional Ownership Brainstorm Cell Therapeutics Institutional Ownership iBio Institutional Ownership Turnstone Biologics Institutional Ownership Aytu BioPharma Institutional Ownership This page (NASDAQ:EVAX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredAI Bloodbath Coming on June 1st?If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evaxion Biotech A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Evaxion Biotech A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.